Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors

Behavioral and Brain Functions

Volumn 3, Issue , 2007, Pages

  Neubert, John K ^a,b,c   Rossi, Heather L ^a,b   Pogar, Jonathan ^a   Jenkins, Alan C ^a   Caudle, Robert M ^a,b,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(3,4 DICHLOROPHENYL)ACETYL] 3 (1 PYRROLIDINYLMETHYL) 1 PIPERAZINECARBOXYLIC ACID METHYL ESTER; ACETIC ACID; CAPSAICIN; GW 89696; KAPPA 2 OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; MU OPIATE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; HEAT SENSITIVITY; LATENT PERIOD; MALE; NEUROGENIC INFLAMMATION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; VISCERAL PAIN; WRITHING TEST;

EID: 35648974654     PISSN: 17449081     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-9081-3-49     Document Type: Article

References (53)

1. Attali B Gouarderes C Mazarguil H Audigier Y Cros J Differential interaction of opiates to multiple "kappa" binding sites in the guinea-pig lumbo-sacral spinal cord Life Sci 1982, 31:1371-1375 10.1016/0024-3205(82)90384-8 6128659
2. Lahti RA Mickelson MM McCall JM Von Voigtlander PF [3H]U-69593 a highly selective ligand for the opioid kappa receptor Eur J Pharmacol 1985, 109:281-284 10.1016/0014-2999(85)90431-5 2986999
3. Keita H Kayser V Guilbaud G Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy Eur J Pharmacol 1995, 277:275-280 10.1016/0014-2999(95)00122-2 7493620
4. Desmeules JA Kayser V Guilbaud G Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain Pain 1993, 53:277-285 10.1016/0304-3959(93)90224-D 8394563
5. Danzebrink RM Green SA Gebhart GF Spinal mu and delta, but not kappa, opioid-receptor agonists attenuate responses to noxious colorectal distension in the rat Pain 1995, 63:39-47 10.1016/0304-3959(94)00275-J 8577489
6. Lee YW Chaplan SR Yaksh TL Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model Neurosci Lett 1995, 199:111-114 10.1016/0304-3940(95)12034-2 8584236
7. Schmauss C Yaksh TL In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat J Pharmacol Exp Ther 1984, 228:1-12 6319664
8. Cvejic S Devi LA Dimerization of the delta opioid receptor: Implication for a role in receptor internalization J Biol Chem 1997, 272:26959-26964 10.1074/jbc.272.43.26959 9341132
9. Jordan BA Devi LA G-protein-coupled receptor heterodimerization modulates receptor function Nature 1999, 399:697-700 10.1038/21441 10385123
10. Gomes I Jordan BA Gupta A Rios C Trapaidze N Devi LA G protein coupled receptor dimerization: Implications in modulating receptor function J Mol Med 2001, 79:226-242 10.1007/s001090100219 11485015
11. Rios CD Jordan BA Gomes I Devi LA G-protein-coupled receptor dimerization: Modulation of receptor function Pharmacol Ther 2001, 92:71-87 10.1016/S0163-7258(01)00160-7 11916530
12. Wessendorf MW Dooyema J Coexistence of kappa- and delta-opioid receptors in rat spinal cord axons Neurosci Lett 2001, 298:151-154 10.1016/ S0304-3940(00)01700-6 11165429
13. Caudle RM Finegold AA Mannes AJ Tobias MD Kenshalo DR Jr. Iadarola MJ Spinal kappa1 and kappa2 opioid binding sites in rats, guinea pigs, monkeys and humans Neuroreport 1998, 9:2523-2525 10.1097/ 00001756-199808030-00018 9721926
14. Eliav E Herzberg U Caudle RM The kappa opioid agonist GR89,696 blocks hyperalgesia and allodynia in rat models of peripheral neuritis and neuropathy Pain 1999, 79:255-264 10.1016/S0304-3959(98)00177-8 10068171
15. Ho J Mannes AJ Dubner R Caudle RM Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation J Pharmacol Exp Ther 1997, 281:136-141 9103490
16. Caudle RM Mannes AJ Iadarola MJ GR89,696 is a kappa-2 opioid receptor agonist and a kappa-1 opioid receptor antagonist in the guinea pig hippocampus J Pharmacol Exp Ther 1997, 283:1342-1349 9400009
17. Caudle RM Chavkin C Dubner R Kappa 2 opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells J Neurosci 1994, 14:5580-5589 7916046
18. Wagner JJ Caudle RM Chavkin C Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus J Neurosci 1992, 12:132-141 1345943
19. Schoffelmeer AN Hogenboom F Mulder AH Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum Br J Pharmacol 1997, 122:520-524 10.1038/ sj.bjp.0701394 9351509
20. Ohsawa M Kamei J Modification of kappa-opioid receptor agonist-induced antinociception by diabetes in the mouse brain and spinal cord J Pharmacol Sci 2005, 98:25-32 10.1254/jphs.FP0040621 15879680
21. Gu B Fraser MO Thor KB Dolber PC Induction of bladder sphincter dyssynergia by kappa-2 opioid receptor agonists in the female rat J Urol 2004, 171:472-477 10.1097/01.ju.0000092069.00376.5c 14665958
22. Fantegrossi WE Kugle KM Valdes LJ 3rd Koreeda M Woods JH Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse Behav Pharmacol 2005, 16:627-633 10.1097/00008877-200512000-00005 16286814
23. Boyle TJ Masuda T Cunningham ST Effects of a kappa agonist, spiradoline mesylate (U62,066E), on activation and vaginocervical-stimulation produced analgesia in rats Brain Res Bull 2001, 54:213-218 10.1016/ S0361-9230(00)00453-6 11275411
24. Cunningham ST Kelley AE Opiate infusion into nucleus accumbens: contrasting effects on motor activity and responding for conditioned reward Brain Res 1992, 588:104-114 10.1016/0006-8993(92)91349-J 1327405
25. McDougall SA Garmsen GM Meier TL Crawford CA Kappa opioid mediated locomotor activity in the preweanling rat: Role of pre- and postsynaptic dopamine receptors Psychopharmacology (Berl) 1997, 133:62-68 10.1007/ s002130050372 9335082
26. Willmore-Fordham CB Krall DM McCurdy CR Kinder DH The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats Neuropharmacology 2007, 53:481-486 10.1016/j.neuropharm.2007.06.008 17681558
27. Kumor KM Haertzen CA Johnson RE Kocher T Jasinski D Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo J Pharmacol Exp Ther 1986, 238:960-968 3018228
28. Szekely JI Miglecz E Ronai AZ Biphasic effects of a potent enkephalin analogue (D-Met2,Pro5)-enkephalinamide and morphine on locomotor activity in mice Psychopharmacology (Berl) 1980, 71:299-301 10.1007/ BF00433065 6779336
29. Browne RG Segal DS Behavioral activating effects of opiates and opioid peptides Biol Psychiatry 1980, 15:77-86 6101965
30. Manzanedo C Aguilar MA Minarro J The effects of dopamine D2 and D3 antagonists on spontaneous motor activity and morphine-induced hyperactivity in male mice Psychopharmacology (Berl) 1999, 143:82-88 10.1007/s002130050922 10227083
31. Belknap JK Riggan J Cross S Young ER Gallaher EJ Crabbe JC Genetic determinants of morphine activity and thermal responses in 15 inbred mouse strains Pharmacol Biochem Behav 1998, 59:353-360 10.1016/ S0091-3057(97)00421-8 9476981
32. Rodriguez-Arias M Broseta I Aguilar MA Minarro J Lack of specific effects of selective D(1) and D(2) dopamine antagonists vs. risperidone on morphine-induced hyperactivity Pharmacol Biochem Behav 2000, 66:189-197 10.1016/S0091-3057(00)00207-0 10837860
33. Milman A Weizman R Rigai T Rice KC Pick CG Behavioral effects of opioid subtypes compared with benzodiazepines in the staircase paradigm Behav Brain Res 2006, 170:141-147 10.1016/j.bbr.2006.02.017 16574254
34. Patti CL Frussa-Filho R Silva RH Carvalho RC Kameda SR Takatsu-Coleman AL Cunha JL Abilio VC Behavioral characterization of morphine effects on motor activity in mice Pharmacol Biochem Behav 2005, 81:923-927 10.1016/ j.pbb.2005.07.004 16083952
35. National Research Council Guide for the Care and Use of Laboratory Animals Washington, D.C., National Academy Press 1996
36. Napieralski JA Banks RJ Chesselet MF Motor and somatosensory deficits following uni- and bilateral lesions of the cortex induced by aspiration or thermocoagulation in the adult rat Exp Neurol 1998, 154:80-88 10.1006/ exnr.1998.6893 9875270
37. Schallert T Fleming SM Leasure JL Tillerson JL Bland ST CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury Neuropharmacology 2000, 39:777-787 10.1016/S0028-3908(00)00005-8 10699444
38. Hargreaves K Dubner R Brown F Flores C Joris J A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia Pain 1988, 32:77-88 10.1016/0304-3959(88)90026-7 3340425
39. Neubert JK Widmer CG Malphurs W Rossi HL Vierck CJ Jr. Caudle RM Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity Pain 2005, 116:386-395 10.1016/ j.pain.2005.05.011 15982812
40. Collier HO Dinneen LC Johnson CA Schneider C The abdominal constriction response and its suppression by analgesic drugs in the mouse Br J Pharmacol Chemother 1968, 32:295-310 4230818
41. Neubert JK Rossi HL Malphurs W Vierck CJ Jr. Caudle RM Differentiation between capsaicin-induced allodynia and hyperalgesia using a thermal operant assay Behav Brain Res 2006, 170:308-315 10.1016/ j.bbr.2006.03.008 16675039
42. Narita M Suzuki T Funada M Misawa M Nagase H Involvement of delta-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice Psychopharmacology (Berl) 1993, 111:423-426 10.1007/BF02253531 7870983
43. Dogrul A Yesilyurt O Effects of Ca2+ channel blockers on apomorphine, bromocriptine and morphine-induced locomotor activity in mice Eur J Pharmacol 1999, 364:175-182 10.1016/S0014-2999(98)00640-2 9932721
44. Longoni R Spina L Di Chiara G Dopaminergic D-1 receptors: Essential role in morphine-induced hypermotility Psychopharmacology (Berl) 1987, 93:401-402 3124172
45. Kuzmin A Sandin J Terenius L Ogren SO Dose- and time-dependent bimodal effects of kappa-opioid agonists on locomotor activity in mice J Pharmacol Exp Ther 2000, 295:1031-1042 11082438
46. Chabal C Jacobson L Schwid HA An objective comparison of intrathecal lidocaine versus fentanyl for the treatment of lower extremity spasticity Anesthesiology 1991, 74:643-646 2008943
47. Vierck CJ Acosta-Rua A Nelligan R Tester N Mauderli A Low dose systemic morphine attenuates operant escape but facilitates innate reflex responses to thermal stimulation J Pain 2002, 3:309-319 10.1054/ jpai.2002.125186 14622755
48. Yeomans DC Cooper BY Vierck CJ Jr. Effects of systemic morphine on responses of primates to first or second pain sensations Pain 1996, 66:253-263 10.1016/0304-3959(96)03082-5 8880848
49. Yeomans DC Cooper BY Vierck CJ Jr. Comparisons of dose-dependent effects of systemic morphine on flexion reflex components and operant avoidance responses of awake non-human primates Brain Res 1995, 670:297-302 10.1016/0006-8993(94)01349-M 7743193
50. Vincler M Maixner W Vierck CJ Jr. Light AR Effects of systemic morphine on escape latency and a hindlimb reflex response in the rat J Pain 2001, 2:83-90 10.1054/jpai.2001.19560 14622829
51. Advokat C Duke M Comparison of morphine-induced effects on thermal nociception, mechanoreception, and hind limb flexion in chronic spinal rats Exp Clin Psychopharmacol 1999, 7:219-225 10.1037/1064-1297.7.3.219 10472509
52. Plone MA Emerich DF Lindner MD Individual differences in the hotplate test and effects of habituation on sensitivity to morphine Pain 1996, 66:265-270 10.1016/0304-3959(96)03048-5 8880849
53. Seguin L Le Marouille-Girardon S Millan MJ Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: A comparison to other classes of antinociceptive agent Pain 1995, 61:325-343 10.1016/0304-3959(94)00194-J 7659444